Akoustis Technologies Inc reports results for the quarter ended in September - Earnings Summary

Aktis Oncology

01/11/2021 12:01

* Akoustis Technologies Inc  AKTS.OQ  reported a quarterly
adjusted loss of 25 cents​​ per share for the quarter ended in
September. The mean expectation of four analysts for the quarter
was for a loss of 20 cents per share.
* Revenue rose 193.7% to $1.87 million from a year ago; 
analysts expected $2.01 million. 
* Akoustis Technologies Inc's reported EPS for the quarter was a
loss of 25 cents​.
* The mean earnings estimate of analysts had fallen by
about 9.3% in the last three months.​ 
* In the last 30 days there have been no negative revisions of
earnings estimates 
* Akoustis Technologies Inc shares had fallen by 22.5% this
quarter and lost 38.5% so far this year.
* The company reported a quarterly loss of $12.85 million.
* Wall Street's median 12-month price target for Akoustis
Technologies Inc is $17.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 4 "strong buy" or "buy," no
"hold" and no "sell" or "strong sell." 
This summary was machine generated November 1 at 12:01 p.m.
 ​All figures in US dollars unless otherwise stated